Sodium current inhibitor ranolazine ameliorates experimentally induced diabetic cardiomyopathy.
- Published in:
- Journal of Research in Pharmacy, 2020, v. 24, n. 6, p. 842, doi. 10.35333/jrp.2020.243
- By:
- Publication type:
- Article
Works matching Diabetic cardiomyopathy
Results: 2607
1
2
Demonstration of the Protective Effect of Vinpocetine in Diabetic Cardiomyopathy.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 16, p. 4637, doi. 10.3390/jcm13164637
- By:
- Publication type:
- Article
3
IL-1β and Statin Treatment in Patients with Myocardial Infarction and Diabetic Cardiomyopathy.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 11, p. 1764, doi. 10.3390/jcm8111764
- By:
- Publication type:
- Article
4
Dihydromyricetin Attenuates Diabetic Cardiomyopathy by Inhibiting Oxidative Stress, Inflammation and Necroptosis via Sirtuin 3 Activation.
- Published in:
- Antioxidants, 2023, v. 12, n. 1, p. 200, doi. 10.3390/antiox12010200
- By:
- Publication type:
- Article
5
(Pro)renin receptor aggravates myocardial pyroptosis in diabetic cardiomyopathy through AMPK-NLRP3 pathway.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1453647
- By:
- Publication type:
- Article
6
(Pro)renin receptor aggravates myocardial pyroptosis in diabetic cardiomyopathy through AMPK-NLRP3 pathway.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1453647
- By:
- Publication type:
- Article
7
Mechanisms of diabetic cardiomyopathy: Focus on inflammation.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 5, p. 2326, doi. 10.1111/dom.16242
- By:
- Publication type:
- Article
8
Effects of icariside II ameliorates diabetic cardiomyopathy in streptozotocin‑induced diabetic rats by activating Akt/NOS/NF‑κB signaling.
- Published in:
- Molecular Medicine Reports, 2018, v. 17, n. 3, p. 4099, doi. 10.3892/mmr.2017.8342
- By:
- Publication type:
- Article
9
Changes of myocardial lipidomics profiling in a rat model of diabetic cardiomyopathy using UPLC/Q-TOF/MS analysis.
- Published in:
- Diabetology & Metabolic Syndrome, 2017, v. 9, p. 1, doi. 10.1186/s13098-017-0249-6
- By:
- Publication type:
- Article
10
Overexpression of miR‐22 attenuates oxidative stress injury in diabetic cardiomyopathy via Sirt 1.
- Published in:
- Cardiovascular Therapeutics, 2018, v. 36, n. 2, p. 1, doi. 10.1111/1755-5922.12318
- By:
- Publication type:
- Article
11
The protective effects of liraglutide in reducing lipid droplets accumulation and myocardial fibrosis in diabetic cardiomyopathy.
- Published in:
- Cellular & Molecular Life Sciences, 2025, v. 82, n. 1, p. 1, doi. 10.1007/s00018-024-05558-9
- By:
- Publication type:
- Article
12
Protective Effects of Ginsenoside Rb1 in Rats with Diabetic Cardiomyopathy.
- Published in:
- Indian Journal of Pharmaceutical Sciences, 2022, v. 84, n. 3, p. 723
- By:
- Publication type:
- Article
13
Neuregulin-4 attenuates diabetic cardiomyopathy by regulating autophagy via the AMPK/mTOR signalling pathway.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01643-0
- By:
- Publication type:
- Article
14
Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria.
- Published in:
- Molecular & Cellular Biochemistry, 2014, v. 386, n. 1/2, p. 233, doi. 10.1007/s11010-013-1861-x
- By:
- Publication type:
- Article
15
Alterations of relaxin and its receptor system components in experimental diabetic cardiomyopathy rats.
- Published in:
- Cell & Tissue Research, 2017, v. 370, n. 2, p. 297, doi. 10.1007/s00441-017-2662-4
- By:
- Publication type:
- Article
16
Expression of farnesyl pyrophosphate synthase is increased in diabetic cardiomyopathy.
- Published in:
- Cell Biology International, 2021, v. 45, n. 7, p. 1393, doi. 10.1002/cbin.11573
- By:
- Publication type:
- Article
17
Study on the mechanism of Astragalus in the treatment of diabetic cardiomyopathy based on network pharmacology and its preliminary verification study.
- Published in:
- Journal of Hainan Medical University, 2022, v. 28, n. 20, p. 23
- By:
- Publication type:
- Article
18
The relationship between Metrnl and diabetic cardiomyopathy and its related molecular mechanism.
- Published in:
- Journal of Hainan Medical University, 2022, v. 28, n. 9, p. 22
- By:
- Publication type:
- Article
19
Emerging Therapy for Diabetic Cardiomyopathy: From Molecular Mechanism to Clinical Practice.
- Published in:
- Biomedicines, 2023, v. 11, n. 3, p. 662, doi. 10.3390/biomedicines11030662
- By:
- Publication type:
- Article
20
血清硫氧还蛋白相互作用蛋白、Ⅲ型纤维蛋白结构域结合蛋白 5 与糖尿病性心肌病的相关性及诊断价值分析.
- Published in:
- Progress in Modern Biomedicine, 2023, v. 23, n. 14, p. 2683, doi. 10.13241/j.cnki.pmb.2023.14.015
- By:
- Publication type:
- Article
21
阿托伐他汀通过RGS6 改善糖尿病心肌病大鼠心功能的作用 及其机制研究.
- Published in:
- Progress in Modern Biomedicine, 2020, v. 20, n. 15, p. 2848, doi. 10.13241/j.cnki.pmb.2020.15.009
- By:
- Publication type:
- Article
22
MiR-146a 通过炎症参与小鼠糖尿病心肌病的机制研究.
- Published in:
- Progress in Modern Biomedicine, 2020, v. 20, n. 5, p. 848, doi. 10.13241/j.cnki.pmb.2020.05.010
- By:
- Publication type:
- Article
23
人参皂苷Rb1通过上调PGC-1α缓解糖尿病心肌病.
- Published in:
- Progress in Modern Biomedicine, 2020, v. 20, n. 1, p. 19, doi. 10.13241/j.cnki.pmb.2020.01.004
- By:
- Publication type:
- Article
24
Carvedilol alleviates diabetic cardiomyopathy in diabetic rats.
- Published in:
- Experimental & Therapeutic Medicine, 2019, v. 17, n. 1, p. 479
- By:
- Publication type:
- Article
25
LncRNA HOTAIR improves diabetic cardiomyopathy by increasing viability of cardiomyocytes through activation of the PI3K/Akt pathway.
- Published in:
- Experimental & Therapeutic Medicine, 2018, v. 16, n. 6, p. 4817, doi. 10.3892/etm.2018.6755
- By:
- Publication type:
- Article
26
Oleanolic acid protects against diabetic cardiomyopathy via modulation of the nuclear factor erythroid 2 and insulin signaling pathways.
- Published in:
- Experimental & Therapeutic Medicine, 2017, v. 14, n. 1, p. 848, doi. 10.3892/etm.2017.4527
- By:
- Publication type:
- Article
27
KLF9 Aggravates Streptozotocin-Induced Diabetic Cardiomyopathy by Inhibiting PPARγ/NRF2 Signalling.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 21, p. 3393, doi. 10.3390/cells11213393
- By:
- Publication type:
- Article
28
The Contribution of Cardiac Fatty Acid Oxidation to Diabetic Cardiomyopathy Severity.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 11, p. 3259, doi. 10.3390/cells10113259
- By:
- Publication type:
- Article
29
BMP-7 Attenuates Inflammation-Induced Pyroptosis and Improves Cardiac Repair in Diabetic Cardiomyopathy.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
30
Protective Effect of Paeonol on Diabetic Cardiomyopathy in Rats.
- Published in:
- Medicinal Plant, 2019, v. 10, n. 2, p. 39, doi. 10.19600/j.cnki.issn2152-3924.2019.02.011
- By:
- Publication type:
- Article
31
Diabetic cardiomyopathy: Pathophysiological mechanisms and cardiac dysfuntion.
- Published in:
- Human & Experimental Toxicology, 2013, v. 32, n. 6, p. 571, doi. 10.1177/0960327112450885
- By:
- Publication type:
- Article
32
Role of Autophagy in Granulocyte-Colony Stimulating Factor Induced Anti-Apoptotic Effects in Diabetic Cardiomyopathy.
- Published in:
- Diabetes & Metabolism Journal, 2021, v. 45, n. 4, p. 594, doi. 10.4093/dmj.2020.0049
- By:
- Publication type:
- Article
33
Role of MicroRNA-34a in Anti-Apoptotic Effects of Granulocyte-Colony Stimulating Factor in Diabetic Cardiomyopathy.
- Published in:
- Diabetes & Metabolism Journal, 2020, v. 44, n. 1, p. 173, doi. 10.4093/dmj.2018.0211
- By:
- Publication type:
- Article
34
Epigenetics of methylation modifications in diabetic cardiomyopathy.
- Published in:
- Frontiers in Endocrinology, 2023, v. 14, p. 1, doi. 10.3389/fendo.2023.1119765
- By:
- Publication type:
- Article
35
Profile of crosstalk between glucose and lipid metabolic disturbance and diabetic cardiomyopathy: Inflammation and oxidative stress.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.983713
- By:
- Publication type:
- Article
36
Diabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage.
- Published in:
- Journal of Diabetes Investigation, 2014, v. 5, n. 6, p. 623, doi. 10.1111/jdi.12250
- By:
- Publication type:
- Article
37
Artemisia vulgaris Extract as a Novel Therapeutic Approach for Reversing Diabetic Cardiomyopathy in a Rat Model.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 8, p. 1046, doi. 10.3390/ph17081046
- By:
- Publication type:
- Article
38
Preclinical evidence and possible mechanisms of cardioprotective effects of resveratrol in diabetic cardiomyopathy: a systematic review and meta-analysis.
- Published in:
- Diabetology & Metabolic Syndrome, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13098-024-01512-8
- By:
- Publication type:
- Article
39
Empagliflozin ameliorates diabetic cardiomyopathy via regulated branched-chain amino acid metabolism and mTOR/p-ULK1 signaling pathway-mediated autophagy.
- Published in:
- Diabetology & Metabolic Syndrome, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13098-023-01061-6
- By:
- Publication type:
- Article
40
Evaluating the Sensitivity of (miR-378) as a Circulatory Screening Biomarker for Diabetic Cardiomyopathy: Comparative Study.
- Published in:
- Medico-Legal Update, 2021, v. 21, n. 1, p. 1301, doi. 10.37506/mlu.v21i1.2500
- By:
- Publication type:
- Article
41
Evaluating the Sensitivity of (miR-378) as a Circulatory Screening Biomarker for Diabetic Cardiomyopathy: Comparative Study.
- Published in:
- Medico-Legal Update, 2021, v. 21, n. 1, p. 912, doi. 10.37506/mlu.v21i1.2432
- By:
- Publication type:
- Article
42
Understanding Diabetic Cardiomyopathy: Insulin Resistance and Beyond.
- Published in:
- Heart International, 2024, v. 18, n. 2, p. 7, doi. 10.17925/HI.2024.18.2.2
- By:
- Publication type:
- Article
43
Duodenal‐jejunal bypass surgery activates eNOS and enhances antioxidant system by activating AMPK pathway to improve heart oxidative stress in diabetic cardiomyopathy rats.
- Published in:
- Journal of Diabetes, 2024, v. 16, n. 7, p. 1, doi. 10.1111/1753-0407.13516
- By:
- Publication type:
- Article
44
Mitochondrial fusion promoter restores mitochondrial dynamics balance and ameliorates diabetic cardiomyopathy in an optic atrophy 1‐dependent way.
- Published in:
- Acta Physiologica, 2020, v. 229, n. 1, p. 1, doi. 10.1111/apha.13428
- By:
- Publication type:
- Article
45
Ginger Extract and Omega-3 Fatty Acids Supplementation: A Promising Strategy to Improve Diabetic Cardiomyopathy.
- Published in:
- Physiological Research, 2024, v. 73, n. 3, p. 351, doi. 10.33549/physiolres.935266
- By:
- Publication type:
- Article
46
Diabetic Cardiomyopathy and Cell Death: Focus on Metal-Mediated Cell Death.
- Published in:
- Cardiovascular Toxicology, 2024, v. 24, n. 2, p. 71, doi. 10.1007/s12012-024-09836-7
- By:
- Publication type:
- Article
47
Progression of Diabetic Cardiomyopathy among Type 2 Diabetic Patients: A Review Article.
- Published in:
- Zagazig University Medical Journal, 2024, v. 30, n. 5, p. 1768, doi. 10.21608/ZUMJ.2024.286222.3367
- By:
- Publication type:
- Article
48
EXPLORING THE MECHANISMS OF ACTION OF ACTIVE CONSTITUENTS IN SCHISANDRAE FRUCTUS FOR THE MANAGEMENT OF DIABETIC CARDIOMYOPATHY.
- Published in:
- Genetics & Applications, 2024, p. 20
- By:
- Publication type:
- Article
49
Reduced Fatty Acid Use from CD36 Deficiency Deteriorates Streptozotocin-Induced Diabetic Cardiomyopathy in Mice.
- Published in:
- Metabolites (2218-1989), 2021, v. 11, n. 12, p. 881, doi. 10.3390/metabo11120881
- By:
- Publication type:
- Article
50
The Role of Renin–Angiotensin System in Diabetic Cardiomyopathy: A Narrative Review.
- Published in:
- Life (2075-1729), 2023, v. 13, n. 7, p. 1598, doi. 10.3390/life13071598
- By:
- Publication type:
- Article